review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | John H Zhang | |
John W Calvert | |||
Julian Cahill | |||
P2860 | cites work | p53 has a direct apoptogenic role at the mitochondria | Q24298888 |
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis | Q24307994 | ||
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis | Q24310597 | ||
Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria | Q24311858 | ||
BOK and NOXA are essential mediators of p53-dependent apoptosis | Q24337595 | ||
Caspases: the executioners of apoptosis | Q24530218 | ||
Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2 | Q24534641 | ||
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 | ||
Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition | Q28115131 | ||
Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins | Q28117928 | ||
Mammalian caspases: structure, activation, substrates, and functions during apoptosis | Q28139429 | ||
Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis | Q28140307 | ||
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 | Q28254119 | ||
Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha | Q28267232 | ||
The complexity of p53 modulation: emerging patterns from divergent signals | Q28284854 | ||
Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling | Q28304324 | ||
Apaf1 is required for mitochondrial pathways of apoptosis and brain development | Q28505574 | ||
Evidence for apoptosis after intercerebral hemorrhage in rat striatum | Q28577314 | ||
Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons | Q28588398 | ||
Caspases: enemies within | Q29547315 | ||
BCL-2 family members and the mitochondria in apoptosis | Q29614427 | ||
Cancer. p53, guardian of the genome | Q29615610 | ||
The Bcl-2 protein family: arbiters of cell survival | Q29618158 | ||
Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9 | Q29618617 | ||
The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results | Q30454281 | ||
The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results | Q30454283 | ||
Blood-brain barrier disturbance following subarachnoid hemorrhage in rabbits | Q30456677 | ||
Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells | Q31864081 | ||
Diffusion MR imaging during acute subarachnoid hemorrhage in rats | Q32012395 | ||
Role of p53 family members in apoptosis | Q33810088 | ||
The Bcl-2 protein family | Q33876776 | ||
A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking | Q33890625 | ||
Apoptosis in neural development and disease | Q33938562 | ||
Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. | Q34011633 | ||
Apoptosis signaling | Q34019359 | ||
An induced proximity model for caspase-8 activation. | Q34065853 | ||
Subarachnoid haemorrhage: epidemiology, risk factors, and treatment options | Q34067390 | ||
Apoptosis in neurodegenerative disorders | Q34186312 | ||
Regulation and function of the p53 tumor suppressor protein | Q34245385 | ||
The mitochondrion in apoptosis: how Pandora's box opens | Q34286386 | ||
Hypoxia links ATR and p53 through replication arrest | Q34324309 | ||
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice | Q34408475 | ||
Cerebrovascular dysfunction after subarachnoid haemorrhage: novel mechanisms and directions for therapy | Q34434692 | ||
The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. | Q34859478 | ||
Apoptosis and brain ischaemia | Q35092250 | ||
Defects in regulation of apoptosis in caspase-2-deficient mice | Q35198808 | ||
Psychosocial outcomes at 18 months after good neurological recovery from aneurysmal subarachnoid haemorrhage | Q35482635 | ||
Role of brain natriuretic peptide in cerebral vasospasm | Q35567373 | ||
Isolation of p53-target genes and their functional analysis | Q35628056 | ||
The importance of p53 location: nuclear or cytoplasmic zip code? | Q35639326 | ||
In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation | Q35664020 | ||
Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage | Q46589088 | ||
Role of p38 mitogen-activated protein kinase on cerebral vasospasm after subarachnoid hemorrhage | Q47672245 | ||
Antivasospastic and brain-protective effects of a hydroxyl radical scavenger (AVS) after experimental subarachnoid hemorrhage | Q48021069 | ||
Haemodynamic and metabolic disturbances in the acute stage of subarachnoid haemorrhage demonstrated by PET. | Q48126864 | ||
Increase in p53 protein expression following cortical infarction in the spontaneously hypertensive rat. | Q48144768 | ||
The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53. | Q48261311 | ||
Blood-brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model | Q48335517 | ||
SAH-induced cerebral vasospasm: unraveling molecular mechanisms of a complex disease | Q48391360 | ||
The protective effect of experimental subarachnoid haemorrhage on sodium dehydrocholate-induced blood-brain barrier disruption | Q48393077 | ||
Stroke: anatomy of a catastrophic event. | Q48459393 | ||
Clinical Syndromes in Cerebral Thrombosis, Hypertensive Hemorrhage, and Ruptured Saccular Aneurysm | Q48484867 | ||
Apoptosis and protein expression after focal cerebral ischemia in rat. | Q48636604 | ||
Ultrastructural changes in the circumventricular organs after experimental subarachnoid hemorrhage. | Q48771390 | ||
Specific caspase pathways are activated in the two stages of cerebral infarction. | Q48798033 | ||
Evidence for p53-mediated modulation of neuronal viability. | Q48884313 | ||
Magnesium and experimental vasospasm. | Q48918921 | ||
Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. | Q48960075 | ||
Intracranial pressure changes following aneurysm rupture. Part 1: clinical and angiographic correlations. | Q48987366 | ||
Oxyhemoglobin produces apoptosis and necrosis in cultured smooth muscle cells. | Q49047579 | ||
Increased cytochrome c-mediated DNA fragmentation and cell death in manganese-superoxide dismutase-deficient mice after exposure to subarachnoid hemolysate. | Q49077130 | ||
Morphological changes of cerebral penetrating arteries in a canine double hemorrhage model. | Q49151344 | ||
Subarachnoid hemorrhage: epidemiology, diagnosis, management, and outcome. | Q49166104 | ||
Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. | Q50510722 | ||
The blood-brain barrier following experimental subarachnoid hemorrhage. Part 1: Response to insult caused by arterial hypertension. | Q50929861 | ||
Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. | Q52496732 | ||
The critical first minutes after subarachnoid hemorrhage. | Q54126251 | ||
Cerebral arterial flow dynamics during aneurysm haemorrhage | Q54157386 | ||
Mechanisms of apoptosis | Q56609201 | ||
Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage | Q67296270 | ||
Intracranial hypertension in patients with ruptured intracranial aneurysm | Q67557050 | ||
Value of transcranial Doppler examination in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage | Q68143760 | ||
Role of protein kinase C in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage | Q70568424 | ||
Temporal profile and significance of metabolic failure and trophic changes in the canine cerebral arteries during chronic vasospasm after subarachnoid hemorrhage | Q70649237 | ||
Cerebral oedema after subarachnoid haemorrhage. Pathogenetic significance of vasopressin | Q71370404 | ||
Intracranial aneurysms | Q71908767 | ||
Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage | Q72041656 | ||
Morphological changes of cerebral arteries in a canine double hemorrhage model | Q74268500 | ||
Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain | Q74284095 | ||
Evidence for apoptosis in human intracranial aneurysms | Q74379940 | ||
Apoptosis in basilar endothelial cells in a canine double hemorrhage model | Q74528838 | ||
Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange | Q74607067 | ||
Heat shock protein expression in cerebral vessels after subarachnoid hemorrhage | Q74618559 | ||
Subarachnoid haemorrhage: what happens to the cerebral arteries? | Q77529124 | ||
Relationship between intracranial pressure and the development of vasospasm after aneurysmal subarachnoid hemorrhage | Q77909060 | ||
SACCULAR INTRACRANIAL ANEURYSMS: AN AUTOPSY STUDY | Q78343707 | ||
Adenosine triphosphate and hemoglobin in vasospastic monkeys | Q79975232 | ||
MRI of acute brainstem ischaemia: cytotoxic versus vasogenic oedema? | Q80348457 | ||
Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage | Q81870720 | ||
Cytochrome C-mediated apoptosis | Q35799945 | ||
Deadly conversations: nuclear-mitochondrial cross-talk | Q35891836 | ||
HIF-1 and p53: communication of transcription factors under hypoxia. | Q35985516 | ||
Caspases: potential targets for regulating cell death. | Q35985520 | ||
The role of p53 in hypoxia-induced apoptosis | Q36113108 | ||
Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death | Q36325171 | ||
Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. | Q36704819 | ||
The molecular biology of apoptosis | Q37688810 | ||
Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia | Q39698671 | ||
Cerebral vasospasm following aneurysmal subarachnoid hemorrhage | Q39826081 | ||
Evolution of early perihemorrhagic changes--ischemia vs. edema: an MRI study in rats | Q40425458 | ||
The genetics of programmed cell death in the nematode Caenorhabditis elegans. | Q40431225 | ||
Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. | Q40477995 | ||
Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. | Q40525549 | ||
Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage | Q40626940 | ||
Predictors of cognitive dysfunction after subarachnoid hemorrhage | Q40667672 | ||
Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats | Q40871800 | ||
Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. | Q40960693 | ||
Tumor suppressor p53 as a component of the tumor necrosis factor-induced, protein kinase PKR-mediated apoptotic pathway in human promonocytic U937 cells | Q41008844 | ||
Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis | Q41115305 | ||
Prediction of symptomatic vasospasm after subarachnoid hemorrhage by rapidly increasing transcranial Doppler velocity and cerebral blood flow changes | Q41117865 | ||
Induction of apoptosis in mature T cells by tumour necrosis factor | Q41293478 | ||
Double identity for proteins of the Bcl-2 family | Q41508318 | ||
To die or not to die: an overview of apoptosis and its role in disease. | Q41694113 | ||
Proteolytic activities that mediate apoptosis | Q41748380 | ||
The pathogenetic and prognostic significance of blood-brain barrier damage at the acute stage of aneurysmal subarachnoid haemorrhage. Clinical and experimental studies | Q42437100 | ||
Subarachnoid hemolysate produces DNA fragmentation in a pattern similar to apoptosis in mouse brain | Q42484686 | ||
Apoptosis of endothelial cells in vessels affected by cerebral vasospasm | Q42486897 | ||
Intracellular calcium, myosin light chain phosphorylation, and contractile force in experimental cerebral vasospasm | Q42519575 | ||
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. | Q42830166 | ||
Both caspase-dependent and caspase-independent pathways may be involved in hippocampal CA1 neuronal death because of loss of cytochrome c From mitochondria in a rat forebrain ischemia model | Q43595514 | ||
Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome | Q43629455 | ||
Subarachnoid hemorrhage induces dynamic changes in regional cerebral metabolism in rats | Q43979741 | ||
Preliminary study of the effects of caspase inhibitors on vasospasm in dog penetrating arteries | Q44077277 | ||
Recovering from subarachnoid haemorrhage: patients' perspective | Q44270347 | ||
Subarachnoid hemorrhage-induced upregulation of the 5-HT1B receptor in cerebral arteries in rats | Q44509095 | ||
Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage | Q44846933 | ||
Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage | Q44848532 | ||
The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin alpha | Q44897099 | ||
Neurovascular protection reduces early brain injury after subarachnoid hemorrhage | Q45025356 | ||
Signaling pathways for early brain injury after subarachnoid hemorrhage | Q45055101 | ||
Relationship of local infarctions to cognitive and psychosocial impairments after aneurysmal subarachnoid hemorrhage | Q45085987 | ||
Multiprofessional follow up of patients after subarachnoid haemorrhage | Q45174006 | ||
Role of p53 and apoptosis in cerebral vasospasm after experimental subarachnoid hemorrhage | Q45281370 | ||
Racial disparities in subarachnoid hemorrhage mortality: Los Angeles County, California, 1985-1998. | Q46084006 | ||
Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage | Q46509145 | ||
P433 | issue | 11 | |
P304 | page(s) | 1341-1353 | |
P577 | publication date | 2006-02-15 | |
P1433 | published in | Journal of Cerebral Blood Flow & Metabolism | Q14663525 |
P1476 | title | Mechanisms of early brain injury after subarachnoid hemorrhage | |
P478 | volume | 26 |
Q38816312 | A Case of Hyperacute Onset of Vasospasm After Aneurysmal Subarachnoid Hemorrhage and Refractory Vasospasm Treated with Intravenous and Intraventricular Nitric Oxide: A Mini Review |
Q41490704 | A novel fluorescent imaging technique for assessment of cerebral vasospasm after experimental subarachnoid hemorrhage |
Q57191019 | AVE 0991 attenuates oxidative stress and neuronal apoptosis via Mas/PKA/CREB/UCP-2 pathway after subarachnoid hemorrhage in rats |
Q34639939 | Activation of nuclear factor-κB in the brain after experimental subarachnoid hemorrhage and its potential role in delayed brain injury |
Q92286736 | Acute changes of pro-inflammatory markers and corticosterone in experimental subarachnoid haemorrhage: A prerequisite for severity assessment |
Q27003355 | Advances in the understanding of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage |
Q52725094 | Aloperine activates the Nrf2-ARE pathway when ameliorating early brain injury in a subarachnoid hemorrhage model. |
Q38717928 | Alterations in the expression of protease-activated receptor 1 and tumor necrosis factor-α in the basilar artery of rats following a subarachnoid hemorrhage |
Q47105336 | Amino Acids in Cerebrospinal Fluid of Patients with Aneurysmal Subarachnoid Haemorrhage: An Observational Study |
Q38755733 | An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage |
Q55146353 | Aneurysmal Subarachnoid Hemorrhage. |
Q54964419 | Anti-TNF-alpha antibody attenuates subarachnoid hemorrhage-induced apoptosis in the hypothalamus by inhibiting the activation of Erk. |
Q52151011 | Anti-Vascular Endothelial Growth Factor Treatment Suppresses Early Brain Injury After Subarachnoid Hemorrhage in Mice. |
Q64926395 | Apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH. |
Q26741216 | Aquaporin-4 and Cerebrovascular Diseases |
Q34091847 | Astaxanthin alleviates early brain injury following subarachnoid hemorrhage in rats: possible involvement of Akt/bad signaling |
Q37117334 | Atorvastatin ameliorates cerebral vasospasm and early brain injury after subarachnoid hemorrhage and inhibits caspase-dependent apoptosis pathway |
Q48397070 | Atrophic enlargement of CSF volume after subarachnoid hemorrhage: correlation with neuropsychological outcome |
Q43593718 | Attenuation of early brain injury and learning deficits following experimental subarachnoid hemorrhage secondary to Cystatin C: possible involvement of the autophagy pathway |
Q41620368 | Baicalin Attenuates Subarachnoid Hemorrhagic Brain Injury by Modulating Blood-Brain Barrier Disruption, Inflammation, and Oxidative Damage in Mice |
Q36289420 | Biphasic activation of nuclear factor-kappa B in experimental models of subarachnoid hemorrhage in vivo and in vitro |
Q34627501 | Blockade of the MEK/ERK pathway with a raf inhibitor prevents activation of pro-inflammatory mediators in cerebral arteries and reduction in cerebral blood flow after subarachnoid hemorrhage in a rat model |
Q35558629 | Blood Metabolomic Predictors of 1-Year Outcome in Subarachnoid Hemorrhage |
Q33712587 | Brain interstitial fluid TNF-alpha after subarachnoid hemorrhage |
Q48449329 | Brainstem opioidergic system is involved in early response to experimental SAH. |
Q40641808 | CHOP silencing reduces acute brain injury in the rat model of subarachnoid hemorrhage |
Q64062527 | Carnosic Acid Mitigates Early Brain Injury After Subarachnoid Hemorrhage: Possible Involvement of the SIRT1/p66shc Signaling Pathway |
Q30380013 | Cerebral Perfusion Pressure and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage |
Q41039125 | Cerebral Taurine Levels are Associated with Brain Edema and Delayed Cerebral Infarction in Patients with Aneurysmal Subarachnoid Hemorrhage. |
Q33697166 | Cerebral inflammatory response and predictors of admission clinical grade after aneurysmal subarachnoid hemorrhage |
Q37459867 | Cerebral oxygen metabolism in neonatal hypoxic ischemic encephalopathy during and after therapeutic hypothermia |
Q51093497 | Cerebral tau is elevated after aneurysmal subarachnoid haemorrhage and associated with brain metabolic distress and poor functional and cognitive long-term outcome. |
Q42911739 | Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: mechanism and therapies |
Q37418272 | Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought |
Q53985364 | Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm. |
Q46058689 | Characteristics and prognostic value of acute catecholamine surge in patients with aneurysmal subarachnoid hemorrhage |
Q28285783 | Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage |
Q35686746 | Clinical translation of nitrite therapy for cardiovascular diseases |
Q48510631 | Comparison of experimental rat models of early brain injury after subarachnoid hemorrhage. |
Q37652820 | Controversies and evolving new mechanisms in subarachnoid hemorrhage. |
Q48544286 | Correlation between nitric oxide and early brain injury after subarachnoid hemorrhage. |
Q47975657 | Critical role of EphA4 in early brain injury after subarachnoid hemorrhage in rat. |
Q38171354 | Current management of delayed cerebral ischemia: update from results of recent clinical trials |
Q51064440 | DLK silencing attenuated neuron apoptosis through JIP3/MA2K7/JNK pathway in early brain injury after SAH in rats. |
Q36242938 | Decreased progranulin levels in patients and rats with subarachnoid hemorrhage: a potential role in inhibiting inflammation by suppressing neutrophil recruitment |
Q52652720 | Deficiency of Tenascin-C Alleviates Neuronal Apoptosis and Neuroinflammation After Experimental Subarachnoid Hemorrhage in Mice. |
Q42128503 | Detection of Neuroinflammation in a Rat Model of Subarachnoid Hemorrhage Using [18F]DPA-714 PET Imaging |
Q92152368 | Diagnosis of elevated intracranial pressure in critically ill adults: systematic review and meta-analysis |
Q34652720 | Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage |
Q36964089 | Downregulating hypoxia-inducible factor-1α expression with perfluorooctyl-bromide nanoparticles reduces early brain injury following experimental subarachnoid hemorrhage in rats |
Q64098732 | Early Antiinflammatory Therapy Attenuates Brain Damage After Sah in Rats |
Q48232578 | Early CT perfusion changes and blood-brain barrier permeability after aneurysmal subarachnoid hemorrhage |
Q42545501 | Early brain injury and subarachnoid hemorrhage: Where are we at present? |
Q35883478 | Early brain injury linearly correlates with reduction in cerebral perfusion pressure during the hyperacute phase of subarachnoid hemorrhage |
Q26823982 | Early brain injury, an evolving frontier in subarachnoid hemorrhage research |
Q41767119 | Early brain injury: a common mechanism in subarachnoid hemorrhage and global cerebral ischemia |
Q48296668 | Early elevated levels of soluble triggering receptor expressed on myeloid cells-1 in subarachnoid hemorrhage patients |
Q48188250 | Early global brain oedema in relation to clinical admission parameters and outcome in patients with aneurysmal subarachnoid haemorrhage |
Q36637976 | Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcome |
Q48671981 | Early platelet activation, inflammation and acute brain injury after a subarachnoid hemorrhage: a pilot study. |
Q52585468 | Effect of early brain infarction after subarachnoid haemorrhage - A systematic review and meta-analysis. |
Q35608589 | Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage |
Q35152170 | Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics |
Q98386506 | Endoplasmic reticulum stress mediates cortical neuron apoptosis after experimental subarachnoid hemorrhage in rats |
Q42468577 | Enhancement of Autophagy by Histone Deacetylase Inhibitor Trichostatin A Ameliorates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats. |
Q37797743 | Erythropoietin for the treatment of subarachnoid hemorrhage: a review. |
Q50202861 | Ethyl pyruvate alleviates early brain injury following subarachnoid hemorrhage in rats. |
Q48447452 | Expression and cell distribution of SENP3 in the cerebral cortex after experimental subarachnoid hemorrhage in rats: a pilot study. |
Q94671460 | Extracellular vesicle-mediated transfer of miR-21-5p from mesenchymal stromal cells to neurons alleviates early brain injury to improve cognitive function via the PTEN/Akt pathway after subarachnoid hemorrhage |
Q28941185 | Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage |
Q36025124 | Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage |
Q89619617 | Hydrogen Inhalation Attenuates Oxidative Stress Related Endothelial Cells Injury After Subarachnoid Hemorrhage in Rats |
Q35216028 | Hydrogen gas ameliorates oxidative stress in early brain injury after subarachnoid hemorrhage in rats. |
Q93088170 | Hydrogen gas therapy improves survival rate and neurological deficits in subarachnoid hemorrhage rats: a pilot study |
Q34269672 | Hydrogen-rich saline alleviates early brain injury via reducing oxidative stress and brain edema following experimental subarachnoid hemorrhage in rabbits. |
Q41185218 | Hyperoxia results in increased aerobic metabolism following acute brain injury. |
Q48449404 | IL-33 expression in the cerebral cortex following experimental subarachnoid hemorrhage in rats. |
Q99604163 | INT-777 attenuates NLRP3-ASC inflammasome-mediated neuroinflammation via TGR5/cAMP/PKA signaling pathway after subarachnoid hemorrhage in rats |
Q43977034 | Increased levels of CSF heart-type fatty acid-binding protein and tau protein after aneurysmal subarachnoid hemorrhage. |
Q48612212 | Inflammasome Proteins in Cerebrospinal Fluid of Patients with Subarachnoid Hemorrhage are Biomarkers of Early Brain Injury and Functional Outcome. |
Q48716501 | Inhibition of c-Jun N-terminal kinase ameliorates early brain injury after subarachnoid hemorrhage through inhibition of a Nur77 dependent apoptosis pathway. |
Q47668704 | Inhibition of c-Jun N-terminal kinase prevents blood-brain barrier disruption and normalizes the expression of tight junction proteins clautin-5 and ZO-1 in a rat model of subarachnoid hemorrhage |
Q33919319 | Insulin like growth factor-I in acute subarachnoid hemorrhage: a prospective cohort study |
Q42374635 | Intracranial pressure after aneurysmal subarachnoid hemorrhage: time to revisit |
Q34362232 | Intrauterine ischemic reperfusion switches the fetal transcriptional pattern from HIF-1α- to P53-dependent regulation in the murine brain |
Q87784243 | Intraventricular Hemorrhage: the Role of Blood Components in Secondary Injury and Hydrocephalus |
Q48251071 | Involvement of Nox2 and Nox4 NADPH oxidases in early brain injury after subarachnoid hemorrhage |
Q42575981 | Iron and Early Brain Injury after Subarachnoid Hemorrhage |
Q30439574 | Isoflurane preconditioning increases B-cell lymphoma-2 expression and reduces cytochrome c release from the mitochondria in the ischemic penumbra of rat brain |
Q35754514 | Isoflurane preconditioning provides neuroprotection against stroke by regulating the expression of the TLR4 signalling pathway to alleviate microglial activation |
Q30429066 | Isoflurane preconditioning reduces oxygen-glucose deprivation-induced neuronal injury via B-cell lymphoma 2 protein |
Q48430037 | LPS Pretreatment Provides Neuroprotective Roles in Rats with Subarachnoid Hemorrhage by Downregulating MMP9 and Caspase3 Associated with TLR4 Signaling Activation. |
Q48216383 | Long-Lasting Cerebral Vasospasm, Microthrombosis, Apoptosis and Paravascular Alterations Associated with Neurological Deficits in a Mouse Model of Subarachnoid Hemorrhage |
Q35112800 | Long-term functional consequences and ongoing cerebral inflammation after subarachnoid hemorrhage in the rat. |
Q38798046 | Loss of Consciousness at Onset of Aneurysmal Subarachnoid Hemorrhage is Associated with Functional Outcomes in Good-Grade Patients |
Q37744921 | Loss of GCN5 leads to increased neuronal apoptosis by upregulating E2F1- and Egr-1-dependent BH3-only protein Bim. |
Q42005031 | Lycopene attenuates early brain injury and inflammation following subarachnoid hemorrhage in rats |
Q36236970 | MFGE8/Integrin β3 pathway alleviates apoptosis and inflammation in early brain injury after subarachnoid hemorrhage in rats. |
Q47931980 | MRI Characterization in the Acute Phase of Experimental Subarachnoid Hemorrhage |
Q41613846 | MSK1 downregulation is associated with neuronal and astrocytic apoptosis following subarachnoid hemorrhage in rats |
Q42020457 | Macrophage-Inducible C-Type Lectin/Spleen Tyrosine Kinase Signaling Pathway Contributes to Neuroinflammation After Subarachnoid Hemorrhage in Rats |
Q48477294 | Matrix metalloproteinase-9 potentiates early brain injury after subarachnoid hemorrhage. |
Q52597698 | Melatonin Regulates Apoptosis and Autophagy Via ROS-MST1 Pathway in Subarachnoid Hemorrhage. |
Q55393389 | Melatonin Treatment Regulates SIRT3 Expression in Early Brain Injury (EBI) Due to Reactive Oxygen Species (ROS) in a Mouse Model of Subarachnoid Hemorrhage (SAH). |
Q58742943 | Melatonin Upregulates Nuclear Factor Erythroid-2 Related Factor 2 (Nrf2) and Mediates Mitophagy to Protect Against Early Brain Injury After Subarachnoid Hemorrhage |
Q48676168 | Melatonin activates the Nrf2-ARE pathway when it protects against early brain injury in a subarachnoid hemorrhage model. |
Q39172176 | Memantine alleviates brain injury and neurobehavioral deficits after experimental subarachnoid hemorrhage |
Q34504672 | Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury |
Q46705153 | Minocycline Protects Against NLRP3 Inflammasome-Induced Inflammation and P53-Associated Apoptosis in Early Brain Injury After Subarachnoid Hemorrhage |
Q35606184 | Minocycline improves functional outcomes, memory deficits, and histopathology after endovascular perforation-induced subarachnoid hemorrhage in rats |
Q92484540 | Mitophagy Reduces Oxidative Stress Via Keap1 (Kelch-Like Epichlorohydrin-Associated Protein 1)/Nrf2 (Nuclear Factor-E2-Related Factor 2)/PHB2 (Prohibitin 2) Pathway After Subarachnoid Hemorrhage in Rats |
Q90127331 | Morphological Characteristics of Neuronal Death After Experimental Subarachnoid Hemorrhage in Mice Using Double Immunoenzymatic Technique |
Q34473745 | Multimodality monitoring, inflammation, and neuroregeneration in subarachnoid hemorrhage |
Q41018599 | Necrostatin-1 attenuates early brain injury after subarachnoid hemorrhage in rats by inhibiting necroptosis |
Q47124231 | Neural Vascular Mechanism for the Cerebral Blood Flow Autoregulation after Hemorrhagic Stroke. |
Q48023056 | Neuritin attenuates early brain injury in rats after experimental subarachnoid hemorrhage |
Q55500370 | Neuroprotective Effect of ZnT3 Knockout on Subarachnoid Hemorrhage. |
Q92702025 | Neuroprotective Role of the Nrf2 Pathway in Subarachnoid Haemorrhage and Its Therapeutic Potential |
Q36938876 | Neuroprotective effect of tea polyphenols on oxyhemoglobin induced subarachnoid hemorrhage in mice |
Q92586572 | New risk score of the early period after spontaneous subarachnoid hemorrhage: For the prediction of delayed cerebral ischemia |
Q38723314 | Nrf2 Weaves an Elaborate Network of Neuroprotection Against Stroke. |
Q48950110 | Nuclear factor-κB/Bcl-XL pathway is involved in the protective effect of hydrogen-rich saline on the brain following experimental subarachnoid hemorrhage in rabbits. |
Q53057389 | Nuclear receptor nur77 promotes cerebral cell apoptosis and induces early brain injury after experimental subarachnoid hemorrhage in rats. |
Q45370559 | Obestatin alleviates subarachnoid haemorrhage-induced oxidative injury in rats via its anti-apoptotic and antioxidant effects. |
Q92960290 | Osteopontin-Enhanced Autophagy Attenuates Early Brain Injury via FAK-ERK Pathway and Improves Long-Term Outcome after Subarachnoid Hemorrhage in Rats |
Q41875483 | Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice |
Q48031731 | PCMT1 Ameliorates Neuronal Apoptosis by Inhibiting the Activation of MST1 after Subarachnoid Hemorrhage in Rats |
Q87879781 | PDGFR-β modulates vascular smooth muscle cell phenotype via IRF-9/SIRT-1/NF-κB pathway in subarachnoid hemorrhage rats |
Q48231767 | Paradoxical undressing associated with subarachnoid hemorrhage in a non-hypothermia case? |
Q47111046 | Peli1 Contributions in Microglial Activation, Neuroinflammatory Responses and Neurological Deficits Following Experimental Subarachnoid Hemorrhage |
Q48196937 | Pentoxifylline Alleviates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage. |
Q48940115 | Possible involvement of cathepsin B/D and caspase-3 in deferoxamine-related neuroprotection of early brain injury after subarachnoid haemorrhage in rats. |
Q48552545 | Potential contribution of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhage. |
Q48467024 | Potential dual role of nuclear factor-kappa B in experimental subarachnoid hemorrhage-induced early brain injury in rabbits. |
Q34635151 | Progesterone administration modulates cortical TLR4/NF-κB signaling pathway after subarachnoid hemorrhage in male rats |
Q47751688 | Prognostic Value of Early S100 Calcium Binding Protein B and Neuron-Specific Enolase in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study. |
Q58591851 | Prospective Multicenter Study of Changes in MTT after Aneurysmal SAH and Relationship to Delayed Cerebral Ischemia in Patients with Good- and Poor-Grade Admission Status |
Q37367617 | Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia |
Q41181418 | Protective effect 3,4-dihydroxyphenylethanol in subarachnoid hemorrhage provoked oxidative neuropathy |
Q30402587 | Protective effects of perfluorooctyl-bromide nanoparticles on early brain injuries following subarachnoid hemorrhage in rats. |
Q33598845 | Protective effects of recombinant osteopontin on early brain injury after subarachnoid hemorrhage in rats |
Q48810795 | Pseudo-continuous arterial spin labelling MRI for non-invasive, whole-brain, serial quantification of cerebral blood flow following aneurysmal subarachnoid haemorrhage. |
Q48496566 | Pterostilbene Attenuates Early Brain Injury Following Subarachnoid Hemorrhage via Inhibition of the NLRP3 Inflammasome and Nox2-Related Oxidative Stress. |
Q49103593 | Quantification of Cerebral Edema After Subarachnoid Hemorrhage. |
Q34429188 | Rat endovascular perforation model |
Q42855751 | Recombinant milk fat globule-EGF factor-8 reduces oxidative stress via integrin β3/nuclear factor erythroid 2-related factor 2/heme oxygenase pathway in subarachnoid hemorrhage rats |
Q33903406 | Recurrent spreading depolarizations after subarachnoid hemorrhage decreases oxygen availability in human cerebral cortex |
Q35762153 | Reduction in oxidative stress by superoxide dismutase overexpression attenuates acute brain injury after subarachnoid hemorrhage via activation of Akt/glycogen synthase kinase-3beta survival signaling |
Q36614373 | Regulation of enhanced cerebrovascular expression of proinflammatory mediators in experimental subarachnoid hemorrhage via the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway |
Q33886521 | Relationship between brain interstitial fluid tumor necrosis factor-α and cerebral vasospasm after aneurysmal subarachnoid hemorrhage |
Q47844911 | Resveratrol protects early brain injury after subarachnoid hemorrhage by activating autophagy and inhibiting apoptosis mediated by the Akt/mTOR pathway |
Q82694375 | Risk factors for three phases of 12-month mortality in 1657 patients from a defined population after acute aneurysmal subarachnoid hemorrhage |
Q90245610 | Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH) |
Q37094037 | Role of HCN channels in neuronal hyperexcitability after subarachnoid hemorrhage in rats. |
Q46750059 | Role of autophagy in early brain injury after subarachnoid hemorrhage in rats |
Q39760477 | Role of gap junctions in early brain injury following subarachnoid hemorrhage |
Q41830315 | Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice |
Q48369198 | Role of matrix metalloproteinase-9 in apoptosis of hippocampal neurons in rats during early brain injury after subarachnoid hemorrhage |
Q48912915 | Rutin Inhibits Neuroinflammation and Provides Neuroprotection in an Experimental Rat Model of Subarachnoid Hemorrhage, Possibly Through Suppressing the RAGE-NF-κB Inflammatory Signaling Pathway. |
Q38169991 | SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials. |
Q52647371 | SIRT1 inhibition by sirtinol aggravates brain edema after experimental subarachnoid hemorrhage. |
Q37526864 | SIRT3 Expression Decreases with Reactive Oxygen Species Generation in Rat Cortical Neurons during Early Brain Injury Induced by Experimental Subarachnoid Hemorrhage. |
Q51291264 | Signaling Pathway in Early Brain Injury after Subarachnoid Hemorrhage: News Update. |
Q43150582 | Simultaneous bedside assessment of global cerebral blood flow and effective cerebral perfusion pressure in patients with intracranial hypertension |
Q43224448 | Simvastatin activates Akt/glycogen synthase kinase-3beta signal and inhibits caspase-3 activation after experimental subarachnoid hemorrhage |
Q37465847 | Sirtuin 1 activation protects against early brain injury after experimental subarachnoid hemorrhage in rats |
Q36029059 | Soluble Toll-Like Receptors 2 and 4 in Cerebrospinal Fluid of Patients with Acute Hydrocephalus following Aneurysmal Subarachnoid Haemorrhage. |
Q90721410 | Sterile Inflammation, Potential Target in Aneurysmal Subarachnoid Hemorrhage |
Q90688507 | Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial |
Q89963831 | Subarachnoid Hemorrhage Induces Dynamic Immune Cell Reactions in the Choroid Plexus |
Q64966423 | Subarachnoid Hemorrhage in Hospitalized Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease: A Nationwide Analysis. |
Q38125678 | Subarachnoid hemorrhage and cerebral vasospasm - literature review |
Q37344132 | Subarachnoid hemorrhage: is it time for a new direction? |
Q50791909 | Systematic model of peripheral inflammation after subarachnoid hemorrhage. |
Q104795015 | TRAF3 mediates neuronal apoptosis in early brain injury following subarachnoid hemorrhage via targeting TAK1-dependent MAPKs and NF-κB pathways |
Q37699958 | Tetramethylpyrazine Protects against Early Brain Injury after Experimental Subarachnoid Hemorrhage by Affecting Mitochondrial-Dependent Caspase-3 Apoptotic Pathway. |
Q92347199 | The Neuroprotective Effects of Necrostatin-1 on Subarachnoid Hemorrhage in Rats Are Possibly Mediated by Preventing Blood-Brain Barrier Disruption and RIP3-Mediated Necroptosis |
Q52147605 | The Ras/Raf/Erk Pathway Mediates the Subarachnoid Hemorrhage-Induced Apoptosis of Hippocampal Neurons Through Phosphorylation of p53. |
Q39223884 | The Role of Autophagy in Subarachnoid Hemorrhage: An Update. |
Q92116217 | The Role of Intracranial Pressure and Subarachnoid Blood Clots in Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats |
Q48035356 | The Subarachnoid Hemorrhage Early Brain Edema Score Predicts Delayed Cerebral Ischemia and Clinical Outcomes |
Q99414986 | The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies |
Q37096738 | The effect of subarachnoid erythrocyte lysate on brain injury: a preliminary study |
Q27028040 | The importance of early brain injury after subarachnoid hemorrhage |
Q34356918 | The myriad essential roles of microRNAs in cardiovascular homeostasis and disease |
Q38213375 | The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. |
Q37479890 | The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies. |
Q40029343 | The role of arterioles and the microcirculation in the development of vasospasm after aneurysmal SAH. |
Q49064990 | The role of intravenous immunoglobulin in the treatment of cerebral vasospasm induced by subarachnoid haemorrhage: an experimental study. |
Q33943701 | The role of microclot formation in an acute subarachnoid hemorrhage model in the rabbit |
Q37365666 | The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage. |
Q33624873 | Thioredoxin-Interacting Protein Mediates Apoptosis in Early Brain Injury after Subarachnoid Haemorrhage |
Q33660621 | Thioredoxin-interacting protein links endoplasmic reticulum stress to inflammatory brain injury and apoptosis after subarachnoid haemorrhage |
Q64236955 | Thromboxane-prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in rats |
Q97520923 | Time Course of Metabolomic Alterations in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage |
Q47131419 | Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid hemorrhage. |
Q33747387 | To look beyond vasospasm in aneurysmal subarachnoid haemorrhage. |
Q45981064 | Topiramate attenuates hippocampal injury after experimental subarachnoid hemorrhage in rabbits. |
Q42634950 | Tozasertib attenuates neuronal apoptosis via DLK/JIP3/MA2K7/JNK pathway in early brain injury after SAH in rats |
Q26825343 | Transition of research focus from vasospasm to early brain injury after subarachnoid hemorrhage |
Q26858772 | Understanding the role of hemodynamics in the initiation, progression, rupture, and treatment outcome of cerebral aneurysm from medical image-based computational studies |
Q55439652 | Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study. |
Q64916851 | c‑Jun N‑terminal kinase inhibition attenuates early brain injury induced neuronal apoptosis via decreasing p53 phosphorylation and mitochondrial apoptotic pathway activation in subarachnoid hemorrhage rats. |
Q45285513 | p53 may play an orchestrating role in apoptotic cell death after experimental subarachnoid hemorrhage |
Q39468813 | α7 nicotinic acetylcholine receptor agonist PNU-282987 attenuates early brain injury in a perforation model of subarachnoid hemorrhage in rats |
Search more.